V920 Approval Status
FDA Approved: No
Brand name: V920
Generic name: rVSV∆G-ZEBOV-GP, live attenuated
Treatment for: Ebola Zaire Disease Prophylaxis
V920 (rVSV∆G-ZEBOV-GP, live attenuated) is an investigational vaccine for Ebola Zaire disease.
Development Status and FDA Approval Process for V920
|Nov 13, 2018||Merck Begins Rolling Submission of Licensure Application for V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.